1. Home
  2. Analysis
  3. Avelox
  4. Tivicay

Avelox and Tivicay drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Avelox (moxifloxacin hydrochloride) and Tivicay (dolutegravir sodium). Common drug interactions include decreased activity among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Avelox and Tivicay. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Avelox?

Avelox has active ingredients of moxifloxacin hydrochloride. It is often used in sinusitis. eHealthMe is studying from 28,651 Avelox users. Check the latest studies of Avelox.

What is Tivicay?

Tivicay has active ingredients of dolutegravir sodium. It is often used in hiv infection. eHealthMe is studying from 9,674 Tivicay users. Check the latest studies of Tivicay.

On Jul, 30, 2026

39 people who take Avelox and Tivicay together, and have interactions are studied.

Avelox and Tivicay drug interactions.

What are the common drug interactions of Avelox and Tivicay, by gender? *:

female:

  1. Decreased activity
  2. Dizziness
  3. Femur fracture
  4. Foot fracture
  5. Glomerular filtration rate decreased
  6. Hip arthroplasty
  7. Intervertebral disc disorder (spinal disc disorder)
  8. Knee arthroplasty
  9. Mobility decreased (ability to move is reduced)
  10. Multiple fractures

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Spinal compression fracture (fracture due to spinal compression on bone)
  4. Blood creatinine increased
  5. Decreased activity
  6. Glomerular filtration rate decreased
  7. Hypertension (high blood pressure)
  8. Kidney fibrosis (excess fibrous connective tissue in kidney)
  9. Quality of life decreased
  10. Cerebral toxoplasmosis (parasitic disease of brain caused by the protozoan toxoplasma gondii)

What are the common drug interactions of Avelox and Tivicay, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Depression
  5. Dyspnoea (difficult or laboured respiration)
  6. Emotional distress
  7. Pain
  8. Renal failure (kidney dysfunction)
  9. Anaemia (lack of blood)
  10. Blood creatinine increased

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Fatigue (feeling of tiredness)
  5. Pain
  6. Quality of life decreased
  7. Renal failure (kidney dysfunction)

40-49:

  1. Dizziness
  2. Renal failure (kidney dysfunction)
  3. Alpha 1 foetoprotein increased
  4. Amyloidosis (a tumour within which amyloid is produced)
  5. Anuria (failure of the kidneys to produce urine)
  6. Arthralgia (joint pain)
  7. Asthenia (weakness)
  8. Bone cyst
  9. Bone density decreased
  10. Cardiac arrest

50-59:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Emotional distress
  5. Pain
  6. Renal failure (kidney dysfunction)
  7. Renal tubular acidosis (medical condition that involves an accumulation of acid in the body due to a failure of the kidneys)
  8. Mobility decreased (ability to move is reduced)
  9. Bone metabolism disorder
  10. Decreased activity

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Carpal tunnel decompression
  4. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  5. Chronic kidney disease
  6. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  7. Drug hypersensitivity
  8. Dyslipidaemia (abnormal amount of lipids)
  9. Dysphagia (a condition in which swallowing is difficult or painful)
  10. Erectile dysfunction

What are the existing conditions these people have? *

  1. Pain: 7 people, 17.95%
  2. Hypersensitivity: 4 people, 10.26%
  3. Fungal Infection: 4 people, 10.26%
  4. Bacterial Infection: 4 people, 10.26%
  5. Nausea And Vomiting: 4 people, 10.26%
  6. Atypical Mycobacterial Infection (infections caused by several types of mycobacterium similar to the germ that causes tuberculosis): 3 people, 7.69%
  7. Cerebral Toxoplasmosis (parasitic disease of brain caused by the protozoan toxoplasma gondii): 3 people, 7.69%
  8. Cough: 3 people, 7.69%
  9. Dyspnea (difficult or laboured breathing): 3 people, 7.69%
  10. Feeding Disorder (when children refuse to eat certain food groups): 3 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Avelox and Tivicay?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Avelox and Tivicay:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Avelox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tivicay:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Avelox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tivicay and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on moxifloxacin hydrochloride and dolutegravir sodium (the active ingredients of Avelox and Tivicay, respectively), and Avelox and Tivicay (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.